The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization

被引:83
作者
Hallas, J
Gaist, D
Bjerrum, L
机构
[1] ODENSE UNIV,INST MED BIOL,DEPT CLIN PHARMACOL,ODENSE,DENMARK
[2] ODENSE UNIV,GEN PRACTICE RES UNIT,ODENSE,DENMARK
关键词
drug utilization; pharmacoepidemiologic database;
D O I
10.1097/00001648-199710000-00009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The emergence of large, computerized pharmacoepidemiologic databases has enabled us to study drug utilization with the individual user as the statistical unit. A recurrent problem in such analyses, however, is the overwhelming volume and complexity of data. We here describe a graphical approach that effectively conveys some essential utilization parameters for a drug. The waiting time distribution for a group of drug users is a charting of their first prescription presentations within a specified time window. For a drug used for chronic treatment, most current users will be captured at the beginning of the window. After a few months, the graph will be dominated by new, Incident users. As examples, we present waiting time distributions for insulin, ulcer drugs, systemic corticosteroids, antidepressants, and disulfiram. Appropriately analyzed and interpreted, the waiting time distributions can provide information about the period prevalence, point prevalence, incidence, duration of use, seasonality, and rate of prescription renewal or relapse for specific drugs. Each of these parameters has a visual correlate. The waiting time distributions may be an informative supplement to conventional drug utilization statistics, and possibly also a useful screening tool for unusual prescribing patterns.
引用
收藏
页码:666 / 670
页数:5
相关论文
共 17 条
  • [1] BREWER C, 1992, ACTA PSYCHIAT SCAND, P51
  • [2] AN EQUILIBRIUM-MODEL OF DRUG UTILIZATION
    CHAN, KWA
    WALKER, AM
    YOOD, RA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (01) : 113 - 121
  • [3] Feller W, 1968, An introduction to probability theory and its applications I, V3
  • [4] MISUSE OF SUMATRIPTAN
    GAIST, D
    SINDRUP, S
    HALLAS, J
    GRAM, LF
    [J]. LANCET, 1994, 344 (8929) : 1090 - 1090
  • [5] Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994
    Gaist, D
    Hallas, J
    Hansen, NCG
    Gram, LF
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (04) : 285 - 289
  • [6] INDIVIDUAL UTILIZATION OF ANTIASTHMA MEDICATION BY YOUNG-ADULTS - A PRESCRIPTION DATABASE ANALYSIS
    HALLAS, J
    HANSEN, NCG
    [J]. JOURNAL OF INTERNAL MEDICINE, 1993, 234 (01) : 65 - 70
  • [7] HALLAS J, 1994, EUR J CLIN PHARMACOL, V47, P367
  • [8] MCNICHOL RW, 1992, AM FAM PHYSICIAN, V45, P1547
  • [9] Petri H, 1991, POST MARKETING SURVE, V5, P57
  • [10] CLINICAL COMPARISON OF SYSTEMIC METHYLPREDNISOLONE ACETATE VERSUS TOPICAL BUDESONIDE IN PATIENTS WITH SEASONAL ALLERGIC RHINITIS
    PICHLER, WJ
    KLINT, T
    BLASER, M
    GRAF, W
    SAUTER, K
    WEISS, S
    WITSCHI, K
    [J]. ALLERGY, 1988, 43 (02) : 87 - 92